Clinical trial
Immunological Response to Influenza Vaccination in Children, Adolescents, and Young Adults: A RCT of FluMist vs. Flucelvax
NCT03982069 is registered in ClinicalTrials.gov with Richard Zimmerman MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunological Response to Influenza Vaccination in Children, Adolescents, and Young Adults: A RCT of FluMist vs. Flucelvax
- Lead sponsor
- Richard Zimmerman MD
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 20, 2019
- Completion date
- December 9, 2020
- Enrollment
- 465 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
immune response, influenza, human